Study on the application of hollow mesoporous polydopamine as a nanoparticle drug carrier in tumor combination therapy
Crossref DOI link: https://doi.org/10.1039/D4NJ03153A
Published Online: 2024
Update policy: https://doi.org/10.1039/rsc_crossmark_policy
Yin, Qingyue
Xu, Liang
Chen, Zekun
Cui, Yidan
Zhao, Wenjing
Geng, Fukang
Tao, Caihong https://orcid.org/0000-0003-1297-6265
Funding for this research was provided by:
Lanzhou Jiaotong University
Accepted Manuscript valid from 2025-09-18
